Building Your Care Team and Long-Term Monitoring
At a Glance
Children with Oliver-McFarlane syndrome need individualized, lifelong follow-up because vision, hormone, movement, learning, and developmental needs can change over time. A coordinated team and transition plan help families address problems early and support independence.
Because Oliver-McFarlane Syndrome (OMS) affects multiple systems in the body, your child’s care will be managed by a team of specialists rather than a single doctor. This “multidisciplinary approach” ensures that each part of the syndrome—from vision and hormones to movement and learning—is monitored by an expert [1][2].
Your role as a parent is often that of a “care coordinator,” helping these different doctors communicate and ensuring that your child’s quality of life remains the top priority throughout their development.
Building Your Specialist Team
While every child’s needs are different, a standard OMS care team typically includes:
- Pediatric Ophthalmologist (or Retina Specialist): They monitor the health of the retina and manage complications like fluid leakage (CNV) [3][1].
- Pediatric Endocrinologist: This specialist manages growth hormone replacement, adrenal health, and pubertal development [4][5].
- Clinical Geneticist: They help confirm the diagnosis, explain the PNPLA6 spectrum, and provide counseling for other family members [6][7].
- Pediatric Neurologist: They monitor for signs of ataxia (balance issues) or other changes in motor skills and coordination [8][9].
- Therapy Team: Physical therapists (PT) help with strength and balance, while occupational therapists (OT) focus on daily living skills and fine motor coordination [10][11].
- Support Services: A developmental pediatrician, low-vision rehabilitation professional, school vision specialist, mental-health professional, or social worker can also be essential, though not every child needs every specialist at all times.
Long-Term Surveillance Framework
There is no “one-size-fits-all” schedule for OMS, but medical literature suggests a pattern of lifelong monitoring. Because symptoms can “evolve”—meaning new hormone deficiencies or vision changes can appear years after the initial diagnosis—regular check-ups are essential [5][11].
Ongoing Monitoring Priorities
| System | What is Monitored? | Why it Matters |
|---|---|---|
| Vision | Visual acuity, retinal imaging (OCT), and light sensitivity [3]. | Early detection of treatable issues like fluid leakage (CNV) [1]. |
| Hormones | Height velocity, pituitary hormone blood panels, and adrenal function [4]. | Ensuring the child has enough energy and is reaching their growth potential [12]. |
| Neurology | Tone, strength, balance, and developmental milestones [8]. | Identifying the need for supportive therapies or equipment early on [11]. |
| Education | Visual processing, cognitive levels, and school performance [7]. | Ensuring the child has the right classroom accommodations (e.g., IEP/504 in the US, or equivalent frameworks elsewhere) [13]. |
Understanding the Neurological Spectrum
One of the most important things to remember is that the “labels” of OMS do not perfectly predict your child’s future. The neurological and cognitive outcomes are highly variable, and it is important to distinguish established progressive features (like retinal degeneration) from emerging ones (endocrine issues) and variable ones (developmental findings):
- Cognitive Development: Some patients followed for decades have shown no cognitive impairment and live as independent adults, though prognosis varies [7][12]. Others may experience intellectual disabilities ranging from mild to significant [11][4].
- Movement and Balance: While some children have no motor issues, others may develop gait disturbances or ataxia [8][9]. Early and ongoing PT and OT can provide “supportive physiotherapy” to improve balance and prevent falls [10].
Supporting Quality of Life
Long-term care is about more than just medical tests; it’s about supporting your child’s ability to participate in the world. This might include:
- Low-Vision Services: Providing tools like magnifiers or orientation and mobility training [14].
- Adrenal Safety: Ensuring teachers and caregivers know how to manage an adrenal emergency [15].
- Developmental Support: Using speech therapy if communication delays occur [11].
While OMS is a lifelong condition, adults have been reported, but prognosis and independence vary based on retinal, endocrine, neurological, and developmental involvement [7][12]. As adolescents approach adulthood, include a transition plan for sharing genetic, endocrine, ophthalmic, and emergency records with adult services. By maintaining a consistent schedule of monitoring and surrounding your child with a supportive care team, you can address challenges as they arise and help your child reach their full potential.
Common questions in this guide
Which specialists should care for a child with Oliver-McFarlane syndrome?
How often should a child with Oliver-McFarlane syndrome be monitored?
Will Oliver-McFarlane syndrome always cause intellectual or movement problems?
What therapies and school supports can help a child with OMS?
How should families prepare for the transition to adult care?
How can families prepare for adrenal emergencies in Oliver-McFarlane syndrome?
Get notified when new evidence is published on Trichomegaly-retina pigmentary degeneration-dwarfism syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Oliver McFarlane syndrome and choroidal neovascularisation: a case report.
Makuloluwa AK, Dodeja R, Georgiou M, et al.
Ophthalmic genetics 2020; (41(5)):451-456 doi:10.1080/13816810.2020.1783689.
PMID: 32586184 - 2
PNPLA6-related syndromic retinal dystrophy: A genetically confirmed case of Boucher-Neuhauser syndrome from the Kingdom of Bahrain.
Almohsen MA, Alasal AE, Jamal HF
Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2026; (40(3)):314-317 doi:10.4103/sjopt.sjopt_223_24.
PMID: 42757075 - 3
Novel variants in PNPLA6 causing syndromic retinal dystrophy.
Wu S, Sun Z, Zhu T, et al.
Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.
PMID: 33141049 - 4
New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.
Du C, Yu T, Liu S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.
PMID: 41846525 - 5
Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.
Xiao P, Gu Y, Qi X, et al.
Frontiers in genetics 2025; (16()):1693876 doi:10.3389/fgene.2025.1693876.
PMID: 41321566 - 6
Case Report: Novel compound heterozygous mutations in PNPLA6 gene associated with Oliver-McFarlane syndrome.
Zheng J, Wang Z, Li K, et al.
Frontiers in genetics 2025; (16()):1660243 doi:10.3389/fgene.2025.1660243.
PMID: 41282473 - 7
Oliver McFarlane syndrome: two new cases and a review of the literature.
Lisbjerg K, Andersen MKG, Bertelsen M, et al.
Ophthalmic genetics 2021; (42(4)):464-473 doi:10.1080/13816810.2021.1904419.
PMID: 33818269 - 8
PNPLA6 disorders: what's in a name?
Liu J, Hufnagel RB
Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.
PMID: 37732399 - 9
Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias.
Teive HAG, Camargo CHF, Sato MT, et al.
Cerebellum (London, England) 2018; (17(3)):380-385 doi:10.1007/s12311-017-0909-y.
PMID: 29248984 - 10
Homozygous PNPLA6 Mutation (p.Arg1183Trp) Associated With Isolated Cerebellar Ataxia: A Familial Case Report.
Alawadhi A, Almarzooqi A, Khan M, Alrukn S
Cureus 2026; (18(4)):e107039 doi:10.7759/cureus.107039.
PMID: 42147656 - 11
Identification of Oliver-McFarlane syndrome caused by novel compound heterozygous variants of PNPLA6.
Liu F, Ji Y, Li G, et al.
Gene 2020; (761()):145027 doi:10.1016/j.gene.2020.145027.
PMID: 32758583 - 12
Fertility outcomes and management of long-term pubertal testosterone replacement sequelae in Oliver-McFarlane syndrome: a case report and literature review.
Moshe S, Dekel Y, Oron G, Kabha M
AME case reports 2026; (10()):116 doi:10.21037/acr-2026-0024.
PMID: 42299415 - 13
Approach to inherited retinal diseases.
Ratra D, Ozdek S, Raviselvan M, et al.
Indian journal of ophthalmology 2022; (70(7)):2305-2315 doi:10.4103/ijo.IJO_314_22.
PMID: 35791111 - 14
"My child can't see"-workup and management of children with low vision: a joint workshop of the AAPOS Low Vision Rehabilitation and Genetic Eye Diseases Committees.
Ditta L, Utz VM, Chandna A, et al.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2025; (29(3)):104229 doi:10.1016/j.jaapos.2025.104229.
PMID: 40441479 - 15
Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.
Miller BS, Spencer SP, Geffner ME, et al.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2020; (68(1)):16-25 doi:10.1136/jim-2019-000999.
PMID: 30819831
This page is for informational purposes only and does not constitute medical advice about your child’s Oliver-McFarlane syndrome care. Your child’s specialists should set the monitoring schedule and treatment plan for their individual needs.